John C.K. Milligan, IV

2016

In 2016, John C.K. Milligan, IV earned a total compensation of $784.1K as President and Secretary at TherapeuticsMD, a 75% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$315,000
Salary$450,000
Other$19,079
Total$784,079

Milligan received $450K in salary, accounting for 57% of the total pay in 2016.

Milligan also received $315K in non-equity incentive plan and $19.1K in other compensation.

Rankings

In 2016, John C.K. Milligan, IV's compensation ranked 9,376th out of 14,075 executives tracked by ExecPay. In other words, Milligan earned more than 33.4% of executives.

ClassificationRankingPercentile
All
9,376
out of 14,075
33rd
Division
Manufacturing
3,626
out of 5,489
34th
Major group
Chemicals And Allied Products
1,256
out of 1,895
34th
Industry group
Drugs
998
out of 1,538
35th
Industry
Pharmaceutical Preparations
786
out of 1,176
33rd
Source: SEC filing on April 25, 2017.

Milligan's colleagues

We found four more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2016.

2016

Robert Finizio

TherapeuticsMD

Chief Executive Officer

2016

Daniel Cartwright

TherapeuticsMD

Chief Financial Officer

2016

Mitchell Krassan

TherapeuticsMD

Executive Vice President and Chief Strategy Officer

2016

Michael Donegan

TherapeuticsMD

Vice President - Finance

News

You may also like